Deepverge PLC Skin Trust Club wins Best New Disrupter Brand
June 01 2022 - 8:36AM
RNS Non-Regulatory
TIDMDVRG
Deepverge PLC
01 June 2022
1 June 2022
DeepVerge PLC
("DeepVerge" or "the Company")
Skin Trust Club wins Best New Disrupter Brand at the Pure Beauty
Global Awards 2022
Brand recognition gaining traction
DeepVerge Shanghai office re-opens post COVID-19 lockdowns
DeepVerge (LSE:DVRG.L) consumer skin test subsidiary brand Skin
Trust Club has won the Best New Disrupter Brand award at the Pure
Beauty Global Awards 2022. Now in its fifth year, the Pure Beauty
Global Awards attracted over 500 entries from more than 40
countries across the globe and were judged by a panel of highly
respected industry experts.
Skin Trust Club incorporates an artificial intelligence Skincare
App and Home Test Kit that provide simple, at-home skin microbiome
testing for personalised skincare and skin health tracking. The
self-administered skin swab is a remote trial and allows the
participant to conduct each stage of the trial without interaction.
Skin Trust Club's test generates a report that consumers can use to
manage their custom skincare regime. Analysis of skin attributes
provides information to create hundreds of different product
combinations to suit a person's unique skin microbiome.
Gerard Brandon, CEO of DeepVerge, comments:
"We are delighted to receive this award in recognition of the
incredible pace at which Skin Trust Club has gained a strong global
reputation of providing personalised daily skincare routine
guidance based on our scientific heritage. People now recognise the
importance of skin and want to understand how best to protect it.
Through our app, members receive a report based on a single swab to
find out their unique skin biome, in real-time, and within their
environment, to empower and inform their choice of skincare
routine. Skin Trust Club is truly the holy grail of scientific
based skin care. This award clearly shows the demand which we only
expect to grow over the coming year.
On another note, we are relieved that restrictions are easing in
China and our office in Shanghai is back open for business. The
team have continued their incredible work throughout the pandemic,
and I would like to thank them for their commitment and dedication
during these challenging times."
For further information please contact:
+44 (0) 7340 055
DeepVerge plc Gerard Brandon, CEO 648
SPARK Advisory Partners Limited Neil Baldwin/Andrew +44 (0) 113 370
(Nominated Adviser) Emmott 8974
Turner Pope Investments (TPI) Andy Thacker/James +44 (0) 20 3657
Limited (Broker) Pope 0050
About DeepVerge plc (www.deepverge.com)
DeepVerge is an environmental and life science group of
companies that develops and applies AI and IoT technology to
analytical instruments for the analysis and identification of
bacteria, virus and toxins. Utilising artificial intelligent data
analytics to scientifically prove the impact of skincare product
claims on skin microbiome for most of the top 20 global cosmetic
company clients and remotely detect and identify in real-time,
dangerous pathogens in wastewater treatment plants, drinking water,
rivers, lakes and reservoirs.
Skin Trust Club
Skin Trust Club incorporates an artificial intelligence Skincare
App and Home Test Kit that provide simple, at-home skin microbiome
testing for personalised skincare and skin health tracking. The
self-administered skin swab is a remote trial and allows the
participant to conduct each stage of the trial without interaction.
Skin Trust Club's DNA Test generates a report that consumers can
use to manage their custom skincare regime. Analysis of skin
attributes provides information to create hundreds of different
product combinations to suit a person's unique skin microbiome.
Labskin (Life Science Division)
Labskin is a 3D human skin equivalent test platform that
scientifically proves the impact of skincare product claims in
healthcare, life sciences, skin microbiome clinical trials,
pharmaceutical and cosmetics industries. Labskin have been
pioneering the development of a laboratory grown human skin
platform for 15 years and is the only commercially available
lab-grown full thickness human skin model that naturally mimic the
skins' microbiome. Labskin's virtual clinical trials with remote
collection of human volunteers' skin microbiome provides a solution
for the collection of volunteer microbiomes to allow for
lab-controlled trials of advanced skin models and human
microbiomes. As the data bank of remote volunteers grow, the higher
the accuracy and increased reliability of virtual product testing
that can be provided to clients, eliminating early human trial and
error testing and resulting in a faster time to market. The Labskin
test platform and protocols help clients maintain an optimum
real-world environment, when testing their new ingredients and
existing products, that shows the positive or negative impact on
skin's natural microflora.
About Reach announcements
Reach is an investor communication service aimed at assisting
listed and unlisted (including AIM quoted) companies to distribute
media only / non-regulatory news releases such as marketing
messages, corporate and product information into the public domain.
An RNS Regulatory announcement is required to be notified under the
AIM Rules for Companies.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAEAAKFEDLAEFA
(END) Dow Jones Newswires
June 01, 2022 08:36 ET (12:36 GMT)
Deepverge (LSE:DVRG)
Historical Stock Chart
From Apr 2024 to May 2024
Deepverge (LSE:DVRG)
Historical Stock Chart
From May 2023 to May 2024